XTANDI Trademark

Trademark Overview

On Tuesday, December 27, 2011, a trademark application was filed for XTANDI with the United States Patent and Trademark Office. The USPTO has given the XTANDI trademark a serial number of 79110148. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, January 17, 2023. This trademark is owned by Astellas Pharma Inc.. The XTANDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of cancer
xtandi

General Information

Serial Number79110148
Word MarkXTANDI
Filing DateTuesday, December 27, 2011
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, January 17, 2023
Registration Number4181564
Registration DateTuesday, July 31, 2012
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 15, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 11, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Wednesday, April 11, 2012ASSIGNED TO EXAMINER
Friday, April 6, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, April 10, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, April 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 31, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, April 11, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 17, 2012APPLICATION FILING RECEIPT MAILED
Wednesday, April 25, 2012NOTICE OF PUBLICATION
Tuesday, May 15, 2012PUBLISHED FOR OPPOSITION
Tuesday, July 31, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, August 30, 2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, August 31, 2012FINAL DISPOSITION PROCESSED
Friday, August 31, 2012FINAL DISPOSITION NOTICE SENT TO IB
Sunday, October 7, 2012NOTIFICATION PROCESSED BY IB
Friday, March 16, 2018REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, January 13, 2022INTERNATIONAL REGISTRATION RENEWED
Saturday, July 13, 2013CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, July 16, 2013CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, February 16, 2018TEAS SECTION 71 & 15 RECEIVED
Tuesday, March 6, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 16, 2018NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Friday, October 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Saturday, April 23, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Thursday, July 7, 2022TEAS SECTION 71 RECEIVED
Tuesday, January 17, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 17, 2023REGISTERED-SEC.71 ACCEPTED
Tuesday, January 17, 2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, April 14, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 14, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 14, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, April 14, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 14, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

xtandi cancer treatment human preparations pharmaceutical